10:59 AM EDT, 07/17/2024 (MT Newswires) -- Kane Biotech ( KNBIF ) on Wednesday said it has received ISO Medical Device Single Audit Program (MDSAP) Quality Certification as a designer, developer and manufacturer of medical devices.

This certification allows Kane to apply for regulatory approval of its revyve Antimicrobial Wound Gel in Canada, Australia, New Zealand and Brazil. MDSAP is an enhancement of Kane's previous quality certification which allowed it to receive U.S. Food and Drug Administration clearance for revyve.